This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed price contract type and a ceiling value of $4,845.85. The order is for 120 tablets of the medication NUBEQA 300 MG, which is used to treat prostate cancer. The ultimate completion date for this order is December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. The DLA is the funding agency for this contract.
Generated 3/2/25, 12:46 AM